Clinical application value of combined detection of Hcy,FA,VitB12 and CA15-3 in breast cancer patients
10.3969/j.issn.1000-484X.2014.10.024
- VernacularTitle:Hcy、FA、VitB12及CA15-3联合检测在乳腺癌患者中的应用价值
- Author:
Cuihong GAO
;
Yuping ZHAO
- Publication Type:Journal Article
- Keywords:
Breast cancer;
Homocysteine;
Folic acid;
Vitamin B12;
CA15-3
- From:
Chinese Journal of Immunology
2014;(10):1408-1409,1412
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the alternation of homocysteine (Hcy),folic acid(FA),CA15-3 and vitaminB12(VitB12) in patients with breast cancer and explore the correlation of them.Methods:The levels of FA ,CA15-3 and VitB12 in serum of 55 breast cancer and 35 benign tumor of breast and 50 controls were measured by electro-chemiluminescence immunoassay ( ECLI ) , the Hcy levels were measured by colorimetric method.Results:Compared with the normal controls and benign tumor of breast cancer ,there were some significantly changes in breast cancer patients including Hcy ,CA15-3 increased and FA ,VitB12 reduced ( P＜0.05 ) ,there were no significant differences in Hcy,FA,CA15-3,VitB12 levels between benign breast tumors and normal controls (P>0.05).Companied with TNM stage increased ,the levels of FA breast cancer groups decreased ,the levels of Hcy,CA15-3 increased.The correlation analysis showed that Hcy was negatively correlated with FA and VitB 12,(r=-0.341,r=-0.540),CA15-3 was negatively correlated with FA, CA15-3 was postively correlated with Hcy (r=0.378,r=-0.361).Conclusion: Serum Hcy,CA15-3,FA and VitB12 detection in patients with breast cancer are helpful in the severity judgment and regimen prognosis .
